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Abstract
Introduction: The aim of the present study was to analyse patients’ knowledge
in the field of neoplastic prophylaxis. 
Material and methods: The research was carried out between 2007 and 2008
in the Provincial Hospital in Bydgoszcz (i.e. general surgery, gynaecology and
obstetrics, urology, breast surgery and thoracic surgery). Altogether 300 patients
(of whom 250 were hospitalized) as well as 50 healthy subjects forming the
control group were invited to participate in the study. A proprietary questionnaire
containing eight multiple choice and another twelve open-ended questions was
used for the purpose of the study. 
Results: Prostate and lung cancer patients were more aware of their diseases
compared to the control group, but the differences were not significant 
(p = 0.85 and p = 0.53 respectively). In the field of screening the patients’
knowledge, it was significantly higher in breast cancer subjects (p = 0.0008)
while there was no difference compared to the control group in the remaining
groups of cancer patients (i.e. colorectal, prostate or uterus cancer). Those most
aware of their condition were patients from small towns (below 50,000), while
subjects living in villages were the least aware. 
Conclusions: Patients showed the greatest amount of knowledge regarding
breast cancer and the least amount regarding prostate cancer. Oncological
awareness in cancer patients was found to be related to variables such as
education, age and residence. No difference was found between patients and
controls, comparing their knowledge of disease symptoms as well as screening
possibilities.
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Introduction
Cancer diseases are a problem of today’s civilization. They are one of
the most dangerous groups of diseases that worries humanity, and the
number of cases and deaths is still rising [1, 2]. It has been estimated that
a half of cancer disease cases could have been prevented. It is known that
effective prophylaxis against cancer diseases exists, that progress in the
branch of oncology is enormous, that many malignant neoplasms can be
cured and in many cases lifespan can be significantly lengthened and the
quality of life can be improved [3, 4]. However, often lack of time, fear of
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disease or a false shame are enough to postpone
diagnostic testing. The most important seems to
be the improvement of people’s health awareness
and the ability to see alarming symptoms in order
to minimize the fear of cancer. Appropriate
education and screening tests could be the key to
minimize the incidence of disease and mortality
from malignant neoplasms (NZ) [5-9].
Material and methods
The assessment of knowledge was conducted
regarding clinical symptoms and the possibilities of
screening tests for malignant neoplasms which
occur most often among hospitalized patients in
wards specializing in treating neoplasms. The
research was conducted between 2007 and 2008
in the SP ZOZ Jan Biziel Provincial Hospital in
Bydgoszcz in the: General Surgery Clinical Ward,
Obstetrics Ward, Women’s Diseases and
Gynaecology as well as the Urology Ward, and also
in the Oncology Centre in Bydgoszcz in the Breast
Diseases Ward and in the Clinical Ward of Breast
and Neoplasms Surgery. Taking part in these tests
were 250 patients hospitalized in these hospitals
and 50 healthy people as a control group, selected
from the employees of the Solec Kujawski Town
Hall. The research method was in the form of
a specially constructed questionnaire. The
respondents were of a different age, sex, place of
residence and level of education. The following was
assumed: if at least one of the basic symptoms or
methods of test screening was correctly mentioned
by the patient, it would then be considered that the
knowledge of symptoms and screening methods
was adequate. The analysis of associations was
carried out by Pearson’s linear correlation and
values of p < 0.05 were considered statistically
significant. The Bioethics Committee of the
Collegium Medicum in Bydgoszcz, Nicolaus
Copernicus University in Torun approved the
studies.
Results
From the group of 300 people tested, 142 people
were hospitalized due to a malignant neoplasm
(MN) of different locations. Knowledge of clinical
symptoms in five of the most common malignant
neoplasms in people diagnosed with MN was
analysed and compared with the group of healthy
people. It was discovered that people with MN had
a better knowledge of the clinical symptoms of
cancer than the control group. The differences were
not statistically significant. Knowledge of clinical
symptoms of breast cancer, colon cancer and
cervical cancer was worse among people
hospitalized for MN. The difference was statistically
significant (p  = 0.033851) only in relation to
knowledge of breast cancer symptoms (Table I).
Knowledge of methods for early detection of the
most common MN among people with diagnosed
MN is very similar to the knowledge of healthy
people. There were no statistically significant
differences found concerning knowledge of
screening methods of colon cancer, prostate cancer
and cervical cancer. However, a larger percentage
of people from the group without MN knew the
principles of breast cancer screening. This difference
was statistically significant (p = 0.000824, Table II).
The tested group was very heterogeneous in age.
Knowledge of clinical symptoms and screening
tests varied depending on age. The largest
percentage of people without knowledge of the
most common clinical symptoms of MN was found
in the youngest and the oldest tested groups.
Differences in knowledge of symptoms and
screening tests of breast cancer and prostate cancer
depending on the age of the tested people are
statistically interchangeable (Tables III-VI).
After the analysis of knowledge of the most
common clinical symptoms of MN in Poland
depending on the place of residence, it was found
that the largest percentage of people who are
familiar with these symptoms live in cities with
a population under 50,000 inhabitants, and the
smallest percentage live in villages. The differences
were statistically significant in relation to
knowledge of clinical symptoms of breast cancer,
colon cancer, prostate cancer and cervical cancer
(Tables VII-X).
Symptoms of breast  Doesn’t know Knows  Total
cancer
People with MN 38.03% 61.97% 100%
54 88 142
People without MN 26.58% 73.42% 100%
42 116 158
Total 96 204 300
Table I. Comparison of knowledge about symptoms
of breast cancer among patients with and without
an MN diagnosis
p = 0.033851
Breast cancer  Doesn’t know Knows  Total
screening
People with MN  47.89% 52.11% 100%
68 74 142
People without MN 29.11% 70.89% 100%
46 112 158
Total 114 186 300
Table II. Comparison of knowledge regarding breast
cancer screening among patients with and without
MN diagnosis
p = 0.000824
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Knowledge concerning breast and cervical cancer
screening tests is found in a large percentage of
tested people. There can be considerable variation
depending on the place of residence. The largest
percentage of people who know these principles
reside in small cities and the smallest percentage
reside in villages. These differences are statistically
significant (Tables XI-XII). Knowledge about
screening tests which are used in the early
detection of colon and prostate cancer is far worse
and does not depend on the place of residence.
Knowledge of the most common clinical
symptoms of MN is the worst in the group of
people with primary education. In this group it was
found that there are 2-5 times fewer people with
such knowledge as compared to those with
secondary and higher education. These differences
were statistically significant (Table XIII).
The knowledge of the possibilities to conduct
screening tests for early detection of the most
common MN in the tested group depended on
education. The possibilities of conducting screening
tests are best known to those with secondary and
higher education. Statistically significant differences
were found in the knowledge of screening for
prostate cancer and cervical cancer (Tables XIV-XV).
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Age [years]/ Doesn’t % Knows %
symptoms of  know
breast cancer
16-30/n = 38 8 21.05 30 78.95
31-50/n = 94 22 23.40 72 76.60
51-70/n = 138 52 37.68 86 62.32
Over 70/n = 30 14 46.67 16 53.33
Total/n = 300 96 204
Table III.  Comparison of knowledge regarding
symptoms of breast cancer depending on age
Age [years]/ Doesn’t % Knows %
symptoms of  know
prostate cancer
16-30/n = 38 31 81.58 7 18.42
31-50/n = 94 54 57.45 40 42.55
51-70/n = 138 99 71.74 39 28.26
Over 70/n = 30 24 80 6 20
Total/n = 300 208 92
Table IV. Comparison of knowledge regarding
symptoms of prostate cancer depending on age
p = 0.012247
Age [years]/ Doesn’t % Knows %
breast cancer  know
screening
16-30/n = 38 14 36.84 24 63.16
31-50/n = 94 29 30.85 65 69.15
51-70/n = 138 55 39.86 83 60.14
Over 70/n = 30 18 53.33 12 46.67
Total/n = 300 116 184
Table VI. Comparison of knowledge regarding breast
cancer screening depending on age
p = 0.154003
Age [years]/ Doesn’t % Knows %
prostate cancer know
screening
16-30/n = 38 38 100 0 0
31-50/n = 94 71 75.53 23 24.47
51-70/n = 138 115 83.33 23 16.67
Over 70/n = 30 24 80 6 20
Total/n = 300 248 52
Table  V.  Comparison of knowledge regarding
prostate cancer screening depending on age
p = 0.009321 p = 0.016212
Place of residence/symptoms of breast cancer Doesn’t know % Knows %
City over 50,000 habitants/n = 135 47 34.81 88 65.19
City under 50,000 habitants/n = 109 20 18.35 89 81.65
Village/n = 56 29 51.79 27 48.21
Total/n = 300 96 204
Table VII. Comparison of knowledge regarding symptoms of breast cancer depending on the place of residence
Place of residence/symptoms of colon cancer                   Doesn’t know % Knows %
City over 50,000 inhabitants/n = 135 81 60 54 40
City under 50,000 inhabitants/n = 109 51 46.79 58 53.21
Village/n = 56 39 69.64 17 30.36
Total/n = 300 171 129
Table VIII. Comparison of knowledge regarding symptoms of colon cancer depending on the place of residence
p = 0.012380
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Discussion
The majority of tests conducted around the
world concerning neoplasm epidemiology
concentrate mainly on the introduction of modern
therapeutic methods in particular types of
neoplasms. The authors emphasize the importance
of prophylaxis in early diagnostics, but still there
are few works which are devoted to the appearance
of cancer diseases depending on the degree of
people's awareness [10]. In research which was
carried out 10 years ago, Chojnacka-Szawłowska
found that the knowledge of clinical symptoms 
of cancer is better among people with cancer
disease [11]. In our research, in a group of 300
people it was found that knowledge of the most
common MN symptoms in Poland is on very
different levels. A significant majority of people
know the clinical symptoms of breast cancer
(204/300), and a minority know the symptoms of
prostate cancer (92/300). Knowledge regarding
breast cancer screening tests is at the highest level;
it is known by 2/3 of the respondents tested
(186/200). The worst concerns prostate cancer
(52/300). The age of the respondents has a large
influence on their knowledge about clinical
symptoms and screening tests. In the 31-70 year
age group this knowledge is the best. People under
31 and over 70 have a significantly worse
Place of residence/symptoms of prostate cancer Doesn’t know % Knows %
City over 50,000 inhabitants/n = 135 103 76.30 32 23.70
City under 50,000 inhabitants/n = 109 61 55.96 48 44.04
Village/n = 56 44 78.57 12 21.43
Total/n = 300 208 92
Table IX. Comparison of knowledge regarding symptoms of prostate cancer depending on the place of residence
p = 0.000715
Place of residence/symptoms of cervical cancer Doesn’t know % Knows %
City over 50,000 inhabitants/n = 135 79 58.52 56 41.48
City under 50,000 inhabitants/n = 109 49 44.95 60 55.05
Village/n = 56 42 75 14 25
Total/n = 300 170 130
Table X. Comparison of knowledge regarding symptoms of cervical cancer depending on the place of residence
p = 0.000940
Place of residence/breast cancer screeningD oesn’t know % Knows %
City over 50,000 inhabitants/n = 135 60 44.44 75 55.56
City under 50,000 inhabitants/n = 109 24 22.02 85 77.89
Village/n = 56 30 53.57 26 46.43
Total/n = 300 114 186
Table XI. Comparison of knowledge regarding breast cancer screening depending on the place of residence
p = 0.000046
Place of residence/colon cancer screeningD oesn’t know % Knows %
City over 50,000 inhabitants/n = 135 87 64.44 48 35.56
City under 50,000 inhabitants/n = 109 70 64.22 39 35.78
Village/n = 56  34 60.71 22 39.29
Total/n = 300 191 109
Table XII. Comparison of knowledge regarding colon cancer screening depending on the place of residence
p = 0.877764
Type of MNV alue of p
Lung cancer 0.002390
Breast cancer 0.005
Colon cancer 0.000005
Prostate cancer 0.001408
Cervical cancer 0.000107
Table XIII. Comparison of knowledge regarding MN
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knowledge regarding it. The difference of
knowledge regarding the clinical symptoms of
breast and prostate cancer and knowledge of
screening tests for the early detection of prostate
cancer and colon cancer is statistically significant.
It seems that one of the main reasons for this state
is the lack of propositions for the most suggested
screening tests for this group of people. On the
basis of the research results it was found that
awareness of MN is very bad in the villages. Only
one in every three respondents had information
regarding clinical symptoms appearing in patients
with lung cancer or breast cancer, and in the case
of prostate cancer, colon cancer and cervical cancer
every fifth respondent. Koper et al. draw attention
to the serious problems of access to information for
people who live in small towns [12]. Much greater
knowledge is shown by respondents from small
towns (up to 50,000 inhabitants). This is probably
due to better access to health care specialists. In
small towns contact with the health services is
easier, because there is usually only one hospital
and a limited amount of specialist clinics. In big
cities with a large amount of hospitals it is harder
to coordinate public education activities. The level
of knowledge regarding the most common MN in
Poland depends on the level of education. Both
knowledge about clinical symptoms and screening
tests are directly proportional to education. The
differences found are statistically significant. The
biggest differences are related to knowledge
regarding symptoms of colon and cervical cancer.
Jokiel et al. carried out similar tests regarding
changes in women’s awareness and health
behaviours concerning cervical cancer prophylaxis.
The results of these tests were similar and
confirmed that elderly women with the lowest
education and who live in villages are the least likely
to undergo prophylaxis tests [13]. This opinion is
confirmed by Bannach et al. on the basis of tests
carried out among women who live in the rural
areas of Kujawsko-Pomorskie [14]. 
Knowledge regarding clinical symptoms of breast
cancer and the possibilities of screening tests 
in the group of healthy people was shown by 
over 80% of the respondents (88% and 82%
respectively). Among hospitalized patients this
knowledge is comparable. Only among patients
treated in the Breast and Neoplastic Surgery Ward
and the Clinical Surgery Ward is it significantly
worse. It seems necessary to intensify public
awareness related to MN. Mayo et al. believe that
proper education is an essential condition for the
effectiveness of screening tests [15]. In 2000 Paul
et al. carried out tests on a group of 700 people who
lived in Australia. The knowledge of screening tests
was analysed and the results were compared to
those from the year 1989. These tests confirmed
the view that education conducted in the 1990s 
had a significant influence on raising health
awareness [16]. It was proved that proper
promotion, cooperation with family doctors and
public awareness increase participation in the tests
[17-19]. Patel et al. found that both after talking with
a doctor and after the re-education of the society
the participation in screening tests definitely
increased (p < 0.0001 and p < 0.014 respectively)
[20]. Special attention should be given to rural
residents, uneducated people, young people and
those over 70 years old. Hurd et al. applied
unconventional methods in the education of
women regarding screening tests for cancer
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Education/prostate cancer screeningD oesn’t know % Knows %
Primary/n = 38 34 89.47 4 10.53
Vocational/n = 77 68 88.31 9 11.69
Secondary/n = 120 103 85.83 17 14.17
Higher/n = 65 43 66.15 22 33.85
Total/n = 300 245 52
Table XIV. Comparison of knowledge regarding prostate cancer screening depending on education
p = 0.001058
Education/cervical cancer screeningD oesn’t know % Knows %
Primary/n = 38 27 71.05 11 28.95
Vocational/n = 77 51 66.23 26 33.77
Secondary/n = 120 64 53.33 56 46.67
Higher/n = 65 22 33.85 43 66.15
Total/n = 300 164 136
Table XV. Comparison of knowledge regarding cervical cancer screening depending on education
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diseases. Its level was adjusted to the perceptive
possibilities of a given group. Applying these
methods there was an increase in participation by
women in the programme by 79% [21]. In Poland
there are many preventive and educational
programmes for different groups in terms of age,
sex, etc. Among the many programmes addressed
e.g. to youth, the best known programme is "Mam
haka na raka" (I have cancer on a hook). 
In order to achieve the expected behaviour
change and teach proper health habits it will take
a number of years, and the process of education
should be ongoing and long-term. That is why the
inclusion of young people in this programme who
are still at the early stages of developing good
health attitudes is so important. Then there is a big
chance to establish positive habits and behaviours
to increase oncological awareness and thereby
reduce the morbidity and mortality rates of cancer
diseases.
In conclusion:
1)  knowledge of the most common malignant
neoplasms is varied; the best knowledge
concerns breast cancer; the worst is prostate
cancer;
2) no difference was found between patients and
controls comparing their knowledge of
symptoms of the disease as well as the screening
possibilities;
3) oncological awareness depends on the age of the
respondents; the greatest amount of knowledge
of neoplasms is shown by respondents who are
31-50 years old;
4) the greatest amount of oncological knowledge
is shown by respondents who live in small towns
(under 50,000 habitants);
5) the higher the respondents’ level of education,
the higher their oncological awareness.
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